Fluidigm Co. (FLDM) Insider Acquires $303,882.52 in Stock

Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. bought 50,987 shares of the firm’s stock in a transaction on Monday, February 5th. The stock was acquired at an average price of $5.96 per share, for a total transaction of $303,882.52. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Thursday, February 1st, Levin Capital Strategies, L.P. bought 152,891 shares of Fluidigm stock. The stock was acquired at an average price of $6.18 per share, for a total transaction of $944,866.38.
  • On Tuesday, January 23rd, Levin Capital Strategies, L.P. bought 6,871 shares of Fluidigm stock. The stock was acquired at an average price of $6.57 per share, for a total transaction of $45,142.47.
  • On Tuesday, January 16th, Levin Capital Strategies, L.P. bought 887 shares of Fluidigm stock. The stock was acquired at an average price of $6.68 per share, for a total transaction of $5,925.16.
  • On Wednesday, January 10th, Levin Capital Strategies, L.P. bought 100,576 shares of Fluidigm stock. The stock was acquired at an average price of $6.34 per share, for a total transaction of $637,651.84.
  • On Wednesday, January 3rd, Levin Capital Strategies, L.P. bought 29 shares of Fluidigm stock. The stock was acquired at an average price of $6.63 per share, for a total transaction of $192.27.
  • On Friday, December 28th, Levin Capital Strategies, L.P. bought 30 shares of Fluidigm stock. The stock was acquired at an average price of $5.82 per share, for a total transaction of $174.60.
  • On Friday, December 29th, Levin Capital Strategies, L.P. bought 11,230 shares of Fluidigm stock. The stock was acquired at an average price of $5.94 per share, for a total transaction of $66,706.20.
  • On Wednesday, December 27th, Levin Capital Strategies, L.P. bought 27,100 shares of Fluidigm stock. The stock was acquired at an average price of $5.88 per share, for a total transaction of $159,348.00.
  • On Friday, December 15th, Levin Capital Strategies, L.P. bought 24,175 shares of Fluidigm stock. The stock was acquired at an average price of $5.84 per share, for a total transaction of $141,182.00.
  • On Tuesday, December 12th, Levin Capital Strategies, L.P. bought 18,569 shares of Fluidigm stock. The stock was acquired at an average price of $5.84 per share, for a total transaction of $108,442.96.

Fluidigm Co. (NASDAQ FLDM) traded down $0.16 on Tuesday, hitting $5.75. The stock had a trading volume of 245,751 shares, compared to its average volume of 179,038. Fluidigm Co. has a 1 year low of $2.52 and a 1 year high of $7.05. The company has a debt-to-equity ratio of 5.00, a current ratio of 3.02 and a quick ratio of 2.46. The stock has a market cap of $223.00, a PE ratio of -2.58 and a beta of 3.24.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Neuberger Berman Group LLC boosted its holdings in shares of Fluidigm by 181.6% in the 3rd quarter. Neuberger Berman Group LLC now owns 5,213,481 shares of the medical research company’s stock worth $26,276,000 after purchasing an additional 3,362,100 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Fluidigm by 46.8% in the 3rd quarter. Russell Investments Group Ltd. now owns 3,447,491 shares of the medical research company’s stock worth $17,370,000 after purchasing an additional 1,099,072 shares in the last quarter. State Street Corp boosted its holdings in shares of Fluidigm by 6.2% in the 2nd quarter. State Street Corp now owns 499,524 shares of the medical research company’s stock worth $2,017,000 after purchasing an additional 29,110 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Fluidigm by 7.2% in the 2nd quarter. Northern Trust Corp now owns 406,560 shares of the medical research company’s stock worth $1,642,000 after purchasing an additional 27,400 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Fluidigm by 70.0% in the 3rd quarter. Bank of New York Mellon Corp now owns 370,427 shares of the medical research company’s stock worth $1,867,000 after purchasing an additional 152,588 shares in the last quarter. Hedge funds and other institutional investors own 93.83% of the company’s stock.

Separately, ValuEngine upgraded Fluidigm from a “strong sell” rating to a “sell” rating in a research note on Monday, October 23rd.

TRADEMARK VIOLATION WARNING: This news story was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.com-unik.info/2018/02/06/fluidigm-co-fldm-insider-acquires-303882-52-in-stock.html.

Fluidigm Company Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit